ArticleJournal of diabetes and metabolic disorders2025
Insulin-like growth factor (IGF) and Insulin-like growth factor binding proteins (IGFBP) as predictors of type 2 diabetes risk in obese adults.
Article in Journal of diabetes and metabolic disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aims: Obesity predisposes to Type 2 Diabetes, however, not all obese persons progress to diabetes; thus, risk stratification among non-diabetes people with obesity is important. Insulin-like Growth Factor-1 and Insulin-like Growth Factor Binding Proteins modulate metabolism and may predict diabetes in high-risk adults. We aim to investigate whether their levels predict future diabetes risk in non-diabetes individuals with obesity. Methods: In this case-cohort analysis nested within the Johns Hopkins GeneSTAR study, 40 incident diabetes cases and 40 random cohort sample with a BMI ≥30 kg/m Results: Higher baseline levels of IGF1, IGFBP1, IGFBP2, IGFBP3, and IGFBP6 predicted decreased odds of developing diabetes over 10 years when adjusted for sex, race, baseline age, and follow-up time. This association remained statistically significant for IGFBP2, IGFBP3, and IGFBP6 after adjusting for fasting baseline glucose. Conclusions: IGF/IGFBP complex proteins may serve as early indicators for diabetes risk beyond fasting glucose levels. Future studies should investigate the functional role of the IGF/IGFBP system in obesity, glucose metabolism, and diabetes prevention. Supplementary Information: The online version contains supplementary material available at 10.1007/s40200-025-01753-y.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.